The US FDA has approved AstraZeneca’s Tagrisso and chemotherapy combination 

AstraZeneca’s combination of AstraZeneca’s blockbuster cancer drug Tagrisso with chemotherapy to treat a type of lung cancer has been approved by the US Food and Drug Administration. 

Share This Post: